“…We used affinity-purified primary antibodies raised against the following molecules (species immunized): MGL (rabbit; see below), DGL␣ [rabbit ], mGluR5 [guinea pig and goat (Uchigashima et al, 2007a)], MAP2 [rabbit and goat ], synaptophysin [guinea pig ], CB 1 receptor [guinea pig (Fukudome et al, 2004)], calretinin [mouse (MAB1568; Millipore Bioscience Research Reagents), rabbit (Miyazaki et al, 2011)], VGluT1 [rabbit and goat (Miyazaki et al, 2003;Miura et al, 2006)], VGluT2 [guinea pig and goat (Miyazaki et al, 2003;Miura et al, 2006)], vesicular inhibitory amino acid transporter [VIAAT; goat (Miyazaki et al, 2003;Miura et al, 2006)], vesicular acetylcholine transporter [VAChT; rabbit ], glial fibrillary acidic protein [GFAP; guinea pig (Hisano et al, 2009)], GLAST [goat (Shibata et al, 1997)], 2Ј,3Ј-cyclic nucleotide 3Ј phosphodiesterase (CNPase; mouse; C5922; Sigma), and Iba1 (rabbit; Wako). For production of the MGL antibody, a cDNA fragment encoding the N-terminal 35 amino acids (NCBI reference sequence NM_011844) was subcloned into BamHI/EcoRI site of pGEX4T-2 plasmid (GE Healthcare) for expression of glutathione S-transferase fusion proteins.…”